IPO
Epigenomics AG announced the financial results for the first quarter of the FY 2019.
Four biotech companies began trading on the Nasdaq this morning. Here’s a look at today’s launches and one rumored IPO.
MorphoSys AG reports results for the first quarter of 2019.
Retrophin, Inc. reported its first quarter 2019 financial results and provided a corporate update.
Vericel Corporation reported financial results for the first quarter ended March 31, 2019, and recent business highlights.
ADL Bionatur Solutions advances the results of selected key performance indicators for the first quarter of 2019 ending March 31, 2019.
Esperion announced that the company will host an analyst and investor day on Thursday, May 30, 2019, beginning at 9:00 a.m. Eastern Time.
Strong Crysvita® (burosumab) Launch Continues with Approximately 730 Patients on Reimbursed Commercial Therapy in the United States
A summary of IPOs from companies in the biotech and pharma world since May 1, 2019.
Sales estimated to double in 2019 and exceed EUR 50 million
PRESS RELEASES